ATS 2001
This article was originally published in The Gray Sheet
Executive Summary
Sessions during May 18-23 meeting will cover occupational lung cancer screening tools, implications of the human genome project for pulmonary vascular disease and lung allograft rejection. Research findings in chronic obstructive pulmonary disease, lung cancer, mechanical ventilation also to be presented at San Francisco conference. To register, call 800/650-6898